Anthropometric Measurements as Predictors of Low Birth Weight Among Tanzanian Neonates: A Hospital-Based Study
November 7, 2025
Brand Name :
Cytotec
Synonyms :
misoprostol
Class :
Miscellaneous Gastrointestinal Agents; Prostaglandins, Endocrine
Dosage Forms & StrengthsÂ
tabletÂ
200mcgÂ
100mcgÂ
NSAID-Induced UlcerÂ
ProphylaxisÂ
200 mcg orally every 6hours with food; may be reduced to 100 mcg every 6hours if a higher dose is not tolerated; the last dose should be taken at bedtimeÂ
Should continue therapy throughout the duration of the therapyÂ
Nonsteroidal Anti-inflammatory Drug-induced UlcersÂ
Prophylaxis
200 mcg orally every 6hours with food; may be reduced to 100 mcg every 6hours if a higher dose is not tolerated; the last dose should be taken at bedtime
Should continue therapy throughout the duration of the therapy
See drug monograph of mifepristone (Mifeprex) for the FDA-approved dose regimen
(off-label):
25 mcg (1/4 of a 100-mcg as oral pill) intravaginally at begin, following repeat at frequent intervals and should not exceed more than 3-6 hours.
The patients who have had a prior caesarean section or major uterine surgery should not use it.
(off-label):
100-200 mcg orally every 4-6 hours
(off-label):
600 mcg orally within one minute of delivery as prophylaxis
800 mcg orally once as treatment
(off-label):
600 mcg orally once
Dose Adjustments
Dosing Modifications
Renal impairment: not to use without caution; half-life, peak plasma concentration, and bioavailability may be enhanced, but it is not evident whether the increases are related to clinical relevance
Dosage Forms & Strengths Â
tabletÂ
100mcgÂ
200mcgÂ
Patients with Fat Malabsorption and Cystic Fibrosis (Off-label)Â
<8 yrs: Safety and efficacy were not establishedÂ
≥8 yrs: 100 mcg orally every 6 hoursÂ
with Fat Malabsorption (Off-label) :
Below 8 yrs: Safety and efficacy were not established
Above 8 yrs: 100 mcg orally every 6 hours
Dosage Forms & Strengths Â
TabletÂ
100mcgÂ
200mcgÂ
NSAID-Induced UlcerÂ
the dose may be taken at 100 mcg every 6 hours and may be increased to 100 mcg/day every 3 days until the desired dose is achieved to avoid the possibility of diarrhoea.Â
Nonsteroidal Anti-inflammatory Drug-induced UlcersÂ
the dose may be taken at 100 mcg every 6 hours and may be increased to 100 mcg/day every 3 days until the desired dose is achieved to avoid the possibility of diarrhoea.
misoprostol: they may increase the toxic effect of antacids
misoprostol: they may increase the toxic effect of antacids
misoprostol: they may increase the toxic effect of antacids
misoprostol: they may increase the toxic effect of antacids
misoprostol: they may increase the toxic effect of antacids
it may enhance the risk of side effects when combined with misoprostol
it may enhance the risk of the side effects when combined with misoprostol
it may enhance the risk of side effects when combined with misoprostol
it may enhance the risk of side effects when combined with misoprostol
it may enhance the risk of side effects when combined with misoprostol
it may enhance the risk of side effects when combined with misoprostol
it may enhance the risk of side effects when combined with misoprostol
it may enhance the risk of side effects when combined with misoprostol
Actions and spectrum:Â
Misoprostol stimulates contractions in the uterus by causing labor or expulsion of conception products. It has cytoprotective effects on the gastric mucosa and inhibits acid secretion by increasing mucus production making it to prevent and treat gastric ulcers induced by NSAIDs. Misoprostol is also used for gynaecological indications like cervical ripening before labor medical termination of pregnancy and postpartum hemorrhage treatment off-label.Â
Adverse Reaction Â
Frequency definedÂ
>10%Â
1-10%Â
Black Box Warning:Â
The warning of misoprostol for pregnant women as it can cause abortion, premature birth, or birth defects. It should not be used to reduce NSAID-induced ulcers in childbearing women unless the patient is at high risk of complications from gastric ulcers and NSAID use and low risk of complications from surgical abortion.Â
Contraindication/Caution:Â
Contraindications include hypersensitivity to misoprostol, pregnancy, women without effective contraception, women with a history of caesarean delivery or major uterine surgery, and patients with inflammatory bowel disease as it may increase the risk of abortion and uterine rupture.Â
Misoprostol treats uterine irregularities but it should be used with caution by women with an IUD in place and those with a hx of cesarean delivery, uterine surgery, previous uterine rupture, anemia, hypotension, dehydration, breastfeeding, allergy to prostaglandins, inflammatory bowel disease (IBD), pregnant women to reduce the risk of NSAID-induced ulcers, and patients receiving magnesium-containing antacids to avoid increased diarrhea risks. It is essential to consult a healthcare professional before using misoprostol.Â
Comorbidities:Â
Misoprostol can cause fluid retention that potentially causing heart failure exacerbation in patients with a history of cardiovascular disease. In renal impairment patients it can lead to potential toxicity. Hepatic impairment may result in reduced drug clearance necessitating dose adjustments. It can also cause bronchoconstriction, exacerbate asthma, and cause uterine contractions that potentially leading to abortion or premature labor in childbearing women. Effective contraception is recommended and pregnancy should be ruled out before treatment. Patients with these conditions should be closely monitored and monitored while taking misoprostol.Â
Pregnancy consideration:Â Â
Pregnancy category: XÂ
Lactation: misoprostol is not recommended during lactation.Â
Pregnancy category:Â
Pharmacology:Â
Misoprostol is a synthetic prostaglandin E1 analog with antisecretory and cytoprotective properties. It works by binding to the prostaglandin E receptor in gastric parietal cells by inhibiting gastric acid secretion and increasing mucus and bicarbonate production to protect the gastrointestinal mucosa. Misoprostol also causes uterine contractions and cervical ripening by binding to the prostaglandin E receptors in the myometrium and cervix.Â
 Pharmacodynamics:Â
Misoprostol binds to smooth muscle cell EP receptors and increase contractions by causing uterine contractions, cervical dilation, and decreased gastric acid secretion. Â
It is used to induce labor, ripen the cervix, terminate pregnancy and manage postpartum hemorrhage thus prevent and treat NSAID-induced stomach ulcers, and induce abortion. Â
Misoprostol stimulates mucus production and bicarbonate secretion in the stomach by preventing and treating NSAID-induced gastric ulcers.Â
Pharmacokinetics:Â
AbsorptionÂ
It is absorbed rapidly after oral administration with peak plasma concentrations occurring within 30 to 60 minutes. Â
The oral bioavailability of 80-85% can also be administered vaginally for cervical ripening and labor induction.Â
DistributionÂ
It is highly protein-bound to plasma proteins and distributed throughout the body including the uterus and gastrointestinal tract and is highly distributed.Â
MetabolismÂ
It is primarily metabolized in the liver through oxidation and hydrolysis forming various active metabolites but most is excreted unchanged in feces.Â
Elimination and excretionÂ
It is primarily eliminated in the feces, half-life is 20 to 40 minutes.Â
Administration:Â
Misoprostol prevents gastric ulcers in patients taking NSAIDs. It can be administered via oral, sublingual, buccal, vaginal, or rectal routes. Â
Patient information leafletÂ
Generic Name: misoprostolÂ
Pronounced: [ mye-so-prah-stole]Â
Why do we use misoprostol?Â
Misoprostol used to prevent stomach ulcers caused by NSAIDs, prepare the cervix for labor induction and speed up labor. It is used in medical abortion with mifepristone to prevent or treat postpartum hemorrhage. It may also be used before certain procedures to soften and open the cervix like dilation and curettage or hysteroscopy.Â